QVT Financial LP historic quarter change: USA Other Stocks, New
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 23 quarters from 2013-06-30 to 2026-06-30, QVT Financial LP opened 74 positions, added to 82, reduced 145 and sold out of 84.
- Q1 2024: Stock VERTEX ENERGY INC; Country of operation United States; Class COM; Shares before 0.
- Q3 2016: Stock AXOVANT SCIENCES LTD; Country of operation —; Class COM; Shares before 0.
- Q2 2016: Stock FITBIT INC; Country of operation —; Class CL A; Shares before 0.
- Q2 2016: Stock MATTRESS FIRM HLDG CORP; Country of operation —; Class COM; Shares before 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1290162), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-14); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-18); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q1 2024 | VERTEX ENERGY INC
CUSIP 92534K107 | United States | COM | 0 | 2,925,000 | +2,925,000 | $0 | $4,065,750 | +$4,065,750 | 2024-05-15 |
|---|
| Q3 2016 | AXOVANT SCIENCES LTD
CUSIP G0750W104 | | COM | 0 | 75,000,000 | +75,000,000 | $0 | $1,050,000,000 | +$1,050,000,000 | 2016-11-14 |
|---|
| Q2 2016 | FITBIT INC
CUSIP 33812L102 | | CL A | 0 | 579,502 | +579,502 | $0 | $7,082,000 | +$7,082,000 | 2016-08-15 |
|---|
| Q2 2016 | MATTRESS FIRM HLDG CORP
CUSIP 57722W106 | | COM | 0 | 130,738 | +130,738 | $0 | $4,386,000 | +$4,386,000 | 2016-08-15 |
|---|
| Q2 2016 | ADURO BIOTECH INC
CUSIP 00739L101 | | COM | 0 | 191,954 | +191,954 | $0 | $2,171,000 | +$2,171,000 | 2016-08-15 |
|---|
| Q1 2016 | XILINX INC
CUSIP 983919101 | | COM | 0 | 236,855 | +236,855 | $0 | $11,234,000 | +$11,234,000 | 2016-05-16 |
|---|
| Q1 2016 | AVEXIS INC
CUSIP 05366U100 | | COM | 0 | 242,756 | +242,756 | $0 | $6,224,000 | +$6,224,000 | 2016-05-16 |
|---|
| Q1 2016 | ALERE INC
CUSIP 01449J105 | | COM | 0 | 100,442 | +100,442 | $0 | $5,083,000 | +$5,083,000 | 2016-05-16 |
|---|
| Q1 2016 | OCWEN FINL CORP
CUSIP 675746309 | | COM NEW | 0 | 300,000 | +300,000 | $0 | $741,000 | +$741,000 | 2016-05-16 |
|---|
| Q4 2015 | SANDISK CORP
CUSIP 80004C101 | | COM | 0 | 387,805 | +387,805 | $0 | $29,469,000 | +$29,469,000 | 2016-02-16 |
|---|
| Q4 2015 | PDVWIRELESS INC
CUSIP 69290R104 | | COM | 0 | 864,301 | +864,301 | $0 | $21,693,000 | +$21,693,000 | 2016-02-16 |
|---|
| Q4 2015 | NORTHSTAR REALTY EUROPE CORP
CUSIP 66706L101 | | COM | 0 | 1,649,225 | +1,649,225 | $0 | $19,477,000 | +$19,477,000 | 2016-02-16 |
|---|
| Q4 2015 | PRONAI THERAPEUTICS INC
CUSIP 74346L101 | | COM | 0 | 70,000 | +70,000 | $0 | $1,053,000 | +$1,053,000 | 2016-02-16 |
|---|
| Q3 2015 | ALTERA CORP
CUSIP 021441100 | | COM | 0 | 358,667 | +358,667 | $0 | $17,962,000 | +$17,962,000 | 2015-11-16 |
|---|
| Q3 2015 | MARVELL TECHNOLOGY GROUP LTD
CUSIP G5876H105 | | ORD | 0 | 1,100,110 | +1,100,110 | $0 | $9,956,000 | +$9,956,000 | 2015-11-16 |
|---|
| Q3 2015 | VIVINT SOLAR INC
CUSIP 92854Q106 | | COM | 0 | 772,214 | +772,214 | $0 | $8,093,000 | +$8,093,000 | 2015-11-16 |
|---|
| Q3 2015 | FIBROCELL SCIENCE INC
CUSIP 315721209 | | COM NEW | 0 | 1,870,556 | +1,870,556 | $0 | $7,202,000 | +$7,202,000 | 2015-11-16 |
|---|
| Q3 2015 | RETROPHIN INC
CUSIP 761299106 | | COM | 0 | 296,570 | +296,570 | $0 | $6,009,000 | +$6,009,000 | 2015-11-16 |
|---|
| Q3 2015 | BELLICUM PHARMACEUTICALS INC
CUSIP 079481107 | | COM | 0 | 317,742 | +317,742 | $0 | $4,617,000 | +$4,617,000 | 2015-11-16 |
|---|
| Q3 2015 | TEEKAY TANKERS LTD
CUSIP Y8565N102 | | CL A | 0 | 667,256 | +667,256 | $0 | $4,604,000 | +$4,604,000 | 2015-11-16 |
|---|
| Q3 2015 | MEDGENICS INC
CUSIP 58436Q203 | | COM NEW | 0 | 267,608 | +267,608 | $0 | $2,093,000 | +$2,093,000 | 2015-11-16 |
|---|
| Q2 2015 | AXOVANT SCIENCES LTD
CUSIP G0750W104 | | COM | 0 | 75,000,000 | +75,000,000 | $0 | $1,528,500,000 | +$1,528,500,000 | 2015-08-14 |
|---|
| Q2 2015 | TEKMIRA PHARMACEUTICALS CORP
CUSIP 87911B209 | | COM | 0 | 16,013,540 | +16,013,540 | $0 | $189,921,000 | +$189,921,000 | 2015-08-14 |
|---|
| Q2 2015 | YAHOO INC
CUSIP 984332106 | | COM | 0 | 1,540,102 | +1,540,102 | $0 | $60,511,000 | +$60,511,000 | 2015-08-14 |
|---|
| Q2 2015 | SANDISK CORP
CUSIP 80004C101 | | COM | 0 | 305,808 | +305,808 | $0 | $17,804,000 | +$17,804,000 | 2015-08-14 |
|---|
| Q2 2015 | ALEXION PHARMACEUTICALS INC
CUSIP 015351109 | | COM | 0 | 60,039 | +60,039 | $0 | $10,853,000 | +$10,853,000 | 2015-08-14 |
|---|
| Q1 2015 | TEKMIRA PHARMACEUTICALS CORP
CUSIP 87911B209 | | COM NEW | 0 | 16,013,540 | +16,013,540 | $0 | $279,596,000 | +$279,596,000 | 2015-05-15 |
|---|
| Q1 2015 | PACIFIC DATAVISION INC
CUSIP 694171307 | | COM | 0 | 754,916 | +754,916 | $0 | $32,559,000 | +$32,559,000 | 2015-05-15 |
|---|
| Q1 2015 | CTRIP COM INTL LTD
CUSIP 22943F100 | | AMERICAN DEP SHS | 0 | 372,146 | +372,146 | $0 | $21,815,000 | +$21,815,000 | 2015-05-15 |
|---|
| Q1 2015 | SOLARCITY CORP
CUSIP 83416T100 | | COM | 0 | 338,416 | +338,416 | $0 | $17,354,000 | +$17,354,000 | 2015-05-15 |
|---|
| Q1 2015 | LION BIOTECHNOLOGIES INC
CUSIP 53619R102 | | COM | 0 | 1,325,000 | +1,325,000 | $0 | $16,046,000 | +$16,046,000 | 2015-05-15 |
|---|
| Q1 2015 | EURONAV NV ANTWERPEN
CUSIP B38564124 | | SHS TEMP | 0 | 606,349 | +606,349 | $0 | $7,313,000 | +$7,313,000 | 2015-05-15 |
|---|
| Q1 2015 | ALTISOURCE RESIDENTIAL CORP
CUSIP 02153W100 | | CL B | 0 | 289,455 | +289,455 | $0 | $6,038,000 | +$6,038,000 | 2015-05-15 |
|---|
| Q1 2015 | TRACON PHARMACEUTICALS INC
CUSIP 89237H100 | | COM | 0 | 368,330 | +368,330 | $0 | $5,001,000 | +$5,001,000 | 2015-05-15 |
|---|
| Q1 2015 | SPARK THERAPEUTICS INC
CUSIP 84652J103 | | COM | 0 | 7,500 | +7,500 | $0 | $581,000 | +$581,000 | 2015-05-15 |
|---|
| Q4 2014 | COVIDIEN PLC
CUSIP G2554F113 | | SHS | 0 | 1,200,000 | +1,200,000 | $0 | $122,736,000 | +$122,736,000 | 2015-02-18 |
|---|
| Q4 2014 | CUBIST PHARMACEUTICALS INC
CUSIP 229678107 | | COM | 0 | 1,200,000 | +1,200,000 | $0 | $120,780,000 | +$120,780,000 | 2015-02-18 |
|---|
| Q4 2014 | LIBERTY INTERACTIVE CORP
CUSIP 53071M880 | | LBT VENT COM A | 0 | 149,842 | +149,842 | $0 | $5,652,000 | +$5,652,000 | 2015-02-18 |
|---|
| Q4 2014 | ASSEMBLY BIOSCIENCES INC
CUSIP 045396108 | | COM | 0 | 535,000 | +535,000 | $0 | $3,867,000 | +$3,867,000 | 2015-02-18 |
|---|
| Q4 2014 | CONCERT PHARMACEUTICALS INC
CUSIP 206022105 | | COM | 0 | 259,999 | +259,999 | $0 | $3,377,000 | +$3,377,000 | 2015-02-18 |
|---|
| Q4 2014 | JUNO THERAPEUTICS INC
CUSIP 48205A109 | | COM | 0 | 30,000 | +30,000 | $0 | $1,567,000 | +$1,567,000 | 2015-02-18 |
|---|
| Q4 2014 | RESTORATION HARDWARE HLDGS I
CUSIP 761283100 | | COM | 0 | 7,531 | +7,531 | $0 | $723,000 | +$723,000 | 2015-02-18 |
|---|
| Q4 2014 | FEDERAL MOGUL HOLDINGS CORP
CUSIP 313549404 | | COM | 0 | 15,581 | +15,581 | $0 | $251,000 | +$251,000 | 2015-02-18 |
|---|
| Q3 2014 | NORTHSTAR RLTY FIN CORP
CUSIP 66704R704 | | COM NEW | 0 | 2,484,167 | +2,484,167 | $0 | $43,895,000 | +$43,895,000 | 2014-11-14 |
|---|
| Q3 2014 | WL ROSS HLDG CORP
CUSIP 92939D104 | | COM SHS | 0 | 1,000,000 | +1,000,000 | $0 | $9,890,000 | +$9,890,000 | 2014-11-14 |
|---|
| Q3 2014 | NORTHSTAR ASSET MGMT GROUP I
CUSIP 66705Y104 | | COM | 0 | 440,028 | +440,028 | $0 | $8,105,000 | +$8,105,000 | 2014-11-14 |
|---|
| Q3 2014 | AVALANCHE BIOTECHNOLOGIES IN
CUSIP 05337G107 | | COM | 0 | 120,000 | +120,000 | $0 | $4,103,000 | +$4,103,000 | 2014-11-14 |
|---|
| Q3 2014 | KITE PHARMA INC
CUSIP 49803L109 | | COM | 0 | 40,000 | +40,000 | $0 | $1,140,000 | +$1,140,000 | 2014-11-14 |
|---|
| Q3 2014 | SPECTRUM BRANDS HLDGS INC
CUSIP 84763R101 | | COM | 0 | 12,200 | +12,200 | $0 | $1,104,000 | +$1,104,000 | 2014-11-14 |
|---|
| Q1 2014 | RETROPHIN INC
CUSIP 761299106 | | COM | 0 | 2,287,583 | +2,287,583 | $0 | $47,908,000 | +$47,908,000 | 2014-05-14 |
|---|
| Q1 2014 | AGENUS INC
CUSIP 00847G705 | United States | COM NEW | 0 | 9,259,260 | +9,259,260 | $0 | $28,137,000 | +$28,137,000 | 2014-05-14 |
|---|
| Q1 2014 | CTRIP COM INTL LTD
CUSIP 22943F100 | | AMERICAN DEP SHS | 0 | 399,000 | +399,000 | $0 | $20,118,000 | +$20,118,000 | 2014-05-14 |
|---|
| Q1 2014 | CONNS INC
CUSIP 208242107 | United States | COM | 0 | 302,995 | +302,995 | $0 | $11,771,000 | +$11,771,000 | 2014-05-14 |
|---|
| Q1 2014 | LIBERTY INTERACTIVE CORP
CUSIP 53071M104 | | INT COM SER A | 0 | 340,700 | +340,700 | $0 | $9,836,000 | +$9,836,000 | 2014-05-14 |
|---|
| Q1 2014 | SCORPIO BULKERS INC
CUSIP Y7546A106 | | SHS | 0 | 864,700 | +864,700 | $0 | $8,742,000 | +$8,742,000 | 2014-05-14 |
|---|
| Q1 2014 | FIVE PRIME THERAPEUTICS INC
CUSIP 33830X104 | | COM | 0 | 301,506 | +301,506 | $0 | $5,928,000 | +$5,928,000 | 2014-05-14 |
|---|
| Q1 2014 | BLUEBIRD BIO INC
CUSIP 09609G100 | United States | COM | 0 | 197,100 | +197,100 | $0 | $4,482,000 | +$4,482,000 | 2014-05-14 |
|---|
| Q1 2014 | NATIONSTAR MTG HLDGS INC
CUSIP 63861C109 | | COM | 0 | 65,900 | +65,900 | $0 | $2,139,000 | +$2,139,000 | 2014-05-14 |
|---|
| Q1 2014 | INTERCEPT PHARMACEUTICALS IN
CUSIP 45845P108 | United States | COM | 0 | 4,251 | +4,251 | $0 | $1,402,000 | +$1,402,000 | 2014-05-14 |
|---|
| Q4 2013 | LUMBER LIQUIDATORS HLDGS INC
CUSIP 55003T107 | United States | COM | 0 | 276,900 | +276,900 | $0 | $28,490,000 | +$28,490,000 | 2014-02-18 |
|---|
| Q4 2013 | ACCELERON PHARMA INC
CUSIP 00434H108 | | COM | 0 | 556,574 | +556,574 | $0 | $21,592,000 | +$21,592,000 | 2014-02-18 |
|---|
| Q4 2013 | ARROWHEAD RESH CORP
CUSIP 042797209 | | COM NEW | 0 | 2,047,782 | +2,047,782 | $0 | $21,108,000 | +$21,108,000 | 2014-02-18 |
|---|
| Q4 2013 | CYTRX CORP
CUSIP 232828509 | | COM PAR $.001 | 0 | 2,075,500 | +2,075,500 | $0 | $13,013,000 | +$13,013,000 | 2014-02-18 |
|---|
| Q4 2013 | NORTHSTAR RLTY FIN CORP
CUSIP 66704R100 | | COM | 0 | 800,001 | +800,001 | $0 | $10,760,000 | +$10,760,000 | 2014-02-18 |
|---|
| Q4 2013 | HOME LN SERVICING SOLUTIONS
CUSIP G6648D109 | | ORD SHS | 0 | 70,000 | +70,000 | $0 | $1,608,000 | +$1,608,000 | 2014-02-18 |
|---|
| Q4 2013 | OREXIGEN THERAPEUTICS INC
CUSIP 686164104 | | COM | 0 | 258,672 | +258,672 | $0 | $1,456,000 | +$1,456,000 | 2014-02-18 |
|---|
| Q4 2013 | ZIPREALTY INC
CUSIP 98974V107 | | COM | 0 | 99,695 | +99,695 | $0 | $558,000 | +$558,000 | 2014-02-18 |
|---|
| Q3 2013 | PHH CORP
CUSIP 693320202 | | COM NEW | 0 | 919,355 | +919,355 | $0 | $21,825,000 | +$21,825,000 | 2013-11-14 |
|---|
| Q3 2013 | ONCOTHYREON INC
CUSIP 682324108 | | COM | 0 | 3,862,099 | +3,862,099 | $0 | $7,956,000 | +$7,956,000 | 2013-11-14 |
|---|
| Q3 2013 | OCWEN FINL CORP
CUSIP 675746309 | | COM NEW | 0 | 140,000 | +140,000 | $0 | $7,808,000 | +$7,808,000 | 2013-11-14 |
|---|
| Q3 2013 | MIRATI THERAPEUTICS INC
CUSIP 60468T105 | United States | COM | 0 | 592,978 | +592,978 | $0 | $6,788,000 | +$6,788,000 | 2013-11-14 |
|---|
| Q3 2013 | ONCONOVA THERAPEUTICS INC
CUSIP 68232V108 | | COM | 0 | 93,950 | +93,950 | $0 | $2,487,000 | +$2,487,000 | 2013-11-14 |
|---|
| Q3 2013 | BLUEBIRD BIO INC
CUSIP 09609G100 | United States | COM | 0 | 75,000 | +75,000 | $0 | $2,022,000 | +$2,022,000 | 2013-11-14 |
|---|
| Q3 2013 | OCERA THERAPEUTICS INC
CUSIP 67552A108 | | COM | 0 | 95,470 | +95,470 | $0 | $809,000 | +$809,000 | 2013-11-14 |
|---|